Novartis and GSK have agreed to provide £2.8m ($3.6m) for the Africa Genomic Research Approach for Diversity and Optimizing Therapeutics (GRADIENT) project (Project Africa GRADIENT), over the next The post Novartis, GSK team up for $3.6m genetic diversity research in Africa appeared first on Pharmaceutical Business review. … [Read more...]

The companies will leverage Cure Genetics’ VELP platform to develop the vectors. Under the partnership, Boehringer’s experience in disease biology and gene therapy development will be combined with The post Cure Genetics, Boehringer to develop AAV vectors for gene therapy appeared first on Pharmaceutical Business review. … [Read more...]

Etana now has the right to sell BYVASDA in the country and in return, Innovent Biologics will receive milestones for the development and commercialisation along with double-digit royalties The post Etana to launch Innovent Biologics’ cancer drug BYVASDA in Indonesia appeared first on Pharmaceutical Business review. … [Read more...]

The viral vector manufacturing arm of Novasep offers contract manufacturing services for vaccines and therapies to biotechnology and biopharma companies. Established over 20 years ago, the business has The post Thermo Fisher Scientific acquires viral vector business from Novasep for $875m appeared first on Pharmaceutical Business review. … [Read more...]

Akron Biotech will produce the Human AB Serum using Octapharma’s solvent-detergent treated human plasma, Octaplas. The Octaplas viral inactivation and production process includes several independent and complementary steps The post Akron Biotech to exclusively manufacture Human AB Serum for Octapharma appeared first on Pharmaceutical Business review. … [Read more...]